指南与共识肺结节与肺癌

基于微观模拟的肺癌筛查个体化推荐:异质性人群研究

Personalizing lung cancer screening recommendations for heterogeneous populations: a microsimulation study
RSS 订阅 · 指南共识 · 肺结节与肺癌筛查 · 2025-11-03

该微观模拟研究模拟美国40至80岁曾吸烟人群,估算肺癌筛查的个体化质量调整生命年获益,并设定两个净获益阈值以区分鼓励筛查、常规劝阻和中性共同决策3类人群。

要点

  • USPSTF符合条件人群中约半数属高净获益,可常规鼓励筛查。
  • 3%USPSTF符合者低净获益应常规劝阻,47%处于偏好敏感的中间区。

核心结论

  • USPSTF肺癌筛查符合人群中约一半属高净获益组,可常规鼓励筛查。
  • 现行 eligibility 标准可能排除大量高净获益和更多中间净获益的曾吸烟者。

研究设计与样本

  • 通过微观模拟估算个体化肺癌筛查的质量调整生命年获益,并设定两个净获益阈值。
  • 将阈值法与现行USPSTF指南进行比较。

关键数值与推荐

  • 设定两个净获益阈值以区分鼓励筛查、常规劝阻和中性共同决策3类人群。
  • 高净获益组可常规鼓励肺癌筛查。
  • 中间灰色区应提供中性共同决策,净获益取决于患者偏好。
  • 低净获益组应常规劝阻筛查。

临床怎么用

  • 对USPSTF符合人群可先评估净获益分层,高净获益者常规鼓励筛查。
  • 对中间灰色区人群应开展中性共同决策,结合患者偏好决定是否筛查。
  • 对低净获益者应常规劝阻肺癌筛查。
  • 现行标准未覆盖的高净获益曾吸烟者值得重新评估筛查资格。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

J Natl Cancer Inst. 2026 Feb 1;118(2):316-324. doi: 10.1093/jnci/djaf316. ABSTRACT BACKGROUND: There is little guidance on how to personalize recommendations for lung cancer screening that accounts for the variation in expected net benefit from screening. We sought to explore the individual and population implications of identifying net benefit thresholds where lung cancer screening could be encouraged, discouraged, or offered as an option through neutral shared decision making due to screening being highly preference sensitive. METHODS: With a simulated US population of 40- to 80-year-old individuals who had ever smoked, we used microsimulation to estimate individualized quality-adjusted life-years saved with lung cancer screening. We then identified 2 net benefit thresholds for lung cancer screening that account for a range of patient preferences and scientific uncertainties and compared this approach with the current United States Preventive Services Task Force (USPSTF) guidelines. RESULTS: Our simulated population included 59 million people. In total, 15 million were USPSTF eligible; of those, 53% (8 million) maintained net benefit, even after accounting for unfavorable preferences about screening. Of the USPSTF population, 3% (450 000) are considered low net benefit (routinely discourage) and 47% (7 million) are in an intermediate gray area, where net benefit depends on patient preferences about lung cancer screening (offer-neutral shared decision making). Among adults who had ever smoked, 2.5 million are high net benefit but excluded by current USPSTF criteria; 20.5 million US adults who had ever smoked are intermediate net benefit but currently excluded by USPSTF criteria. CONCLUSIONS: We estimate that half of the USPSTF lung cancer screening-eligible population is in a high-net-benefit group where lung cancer screening could be routinely encouraged. Current lung cancer screening eligibility criteria likely exclude many ever-smokers who are high net benefit and many more with intermediate net benefit. PMID: 41183085 | PMC: PMC13396146 | DOI: 10.1093/jnci/djaf316

来源:指南共识 · 肺结节与肺癌筛查,查看原文。版权归原作者所有。

引用

  1. 指南共识 · 肺结节与肺癌筛查:Personalizing lung cancer screening recommendations for heterogeneous populations: a microsimulation study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。